RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 39 filers reported holding RAIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,039,335 | -28.2% | 3,526,729 | 0.0% | 0.08% | -30.5% |
| Q2 2023 | $4,232,075 | -86.3% | 3,526,729 | 0.0% | 0.12% | -89.5% |
| Q1 2023 | $30,823,611 | +9.2% | 3,526,729 | 0.0% | 1.13% | -5.4% |
| Q4 2022 | $28,213,832 | +63.9% | 3,526,729 | 0.0% | 1.19% | +67.5% |
| Q3 2022 | $17,210,000 | -12.2% | 3,526,729 | 0.0% | 0.71% | -24.9% |
| Q2 2022 | $19,609,000 | +9.7% | 3,526,729 | 0.0% | 0.95% | +32.4% |
| Q1 2022 | $17,881,000 | -53.1% | 3,526,729 | +19.2% | 0.72% | -48.3% |
| Q4 2021 | $38,097,000 | -13.9% | 2,957,807 | 0.0% | 1.38% | -19.9% |
| Q3 2021 | $44,249,000 | +46.3% | 2,957,807 | +52.0% | 1.73% | +52.3% |
| Q2 2021 | $30,240,000 | – | 1,945,949 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,560,652 | $7,616,000 | 1.78% |
| Cormorant Asset Management, LP | 2,326,660 | $11,354,000 | 0.79% |
| BVF INC/IL | 3,526,729 | $17,210,000 | 0.71% |
| Perceptive Advisors | 2,483,619 | $12,120,000 | 0.35% |
| Boxer Capital, LLC | 1,175,000 | $5,734,000 | 0.32% |
| UBS OCONNOR LLC | 326,451 | $1,593,000,000 | 0.03% |
| Ergoteles LLC | 65,096 | $318,000 | 0.01% |
| Lumina Fund Management LLC | 6,000 | $29,000 | 0.01% |
| Laurion Capital Management LP | 313,200 | $1,528,000 | 0.01% |
| Woodline Partners LP | 119,700 | $584,000 | 0.01% |